Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/524636 stock hub

BOM/524636 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/524636is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.1B

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/524636

In the news

Latest news · BOM/524636

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-51.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/524636 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

130

Groups with data

Currency

INR

Showing 130 of 130 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	175
Employees Change	14%
Employees Change Percent	8.7
Enterprise value	INR 2.8B
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	INR 2.1B
Price	INR 57.79
Price currency	INR
Rev Per Employee	6,447,680x
Sic	2834
Symbol	bom/524636
Website	https://www.oxygentapharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.42%
EV Earnings	-15.98x
EV/Sales	2.47x
P/B ratio	-5.65x
P/S ratio	1.84x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-16.01%
EBITDA Margin	-16.52%
Gross margin	-3.75%
Gross Profit	INR -42.3M
Net Income	INR -174.5M
Pretax Margin	-19.45%
Profit Margin	-15.47%
Profit Per Employee	INR -997,223
Roa5y	-5.86
ROIC	-51.76

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-31.22%
Cagr3y	24.68%
Revenue Growth	60.31x
Revenue Growth Q	2.18x
Revenue Growth3 Y	55.73x
Revenue Growth5 Y	21.21x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 12.4M
Debt	INR 728.3M
Equity	INR -366.8M
Interest Coverage	-5.16
Net Cash	INR -715.9M
Net Cash By Market Cap	INR -34.53
Tangible Book Value	INR -366.8M
Tangible Book Value Per Share	INR -9.89
WACC	6.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-31.2%
200-day SMA	64.45
3Y total return	93.86%
50-day SMA	52.3
50-day SMA vs 200-day SMA	50under200
All Time High	133.5
All Time High Change	-56.71%
All Time High Date	2025-06-09
All Time Low	9.12
All Time Low Change	533.66%
All Time Low Date	2021-07-19
ATR	3.63
Beta	0.52
Beta1y	0.93
Beta2y	0.8
Ch YTD	3.59
High	58.8
High52	133.5
High52 Date	2025-06-09
High52ch	-56.71%
Low	54.43
Low52	45.3
Low52 Date	2026-04-01
Low52ch	27.57%
Ma50ch	10.49%
Price vs 200-day SMA	-10.33%
RSI	53.47
RSI Monthly	47.59
RSI Weekly	46.83
Sharpe ratio	-0.63x
Sortino ratio	-0.79
Total Return	-4.33%
Tr YTD	3.59
Tr1m	16.58%
Tr1w	1.58%
Tr3m	-1.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR -180.7M
Operating margin	-16.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,908,756%
Shares Insiders	29.68%
Shares Out	36,983,500
Shares Qo Q	-1.03%
Shares Yo Y	4.33%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	5,411x
Bv Per Share	-9.89
Ch1m	16.58
Ch1w	1.58
Ch1y	-31.2
Ch3m	-1.21
Ch3y	93.86
Ch6m	-10.36
Change	6.39%
Change From Open	6.15
Close	54.32
Days Gap	0.22
Depreciation Amortization	-5,680,500
Dollar Volume	414,469.9
Earnings Date	2026-05-30
EBIT	INR -180.7M
EBITDA	INR -186.4M
EPS	INR -4.74
F Score	0
Fiscal Year End	March
Founded	1,990
Income Tax	INR -45M
Is Primary Listing	1
Last Earnings Date	2026-02-04
Last Report Date	2025-12-31
Ma150	57.02
Ma150ch	1.35%
Ma20	55.83
Ma20ch	3.51%
Next Earnings Date	2026-05-30
Open	54.44
Position In Range	76.89
Price Date	2026-05-07
Relative Volume	1.33x
Revenue	1,128,344,000x
Tax By Revenue	-3.98x
Tr6m	-10.36%
Volume	7,172

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/524636 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/524636 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/524636?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+29.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.3%

Negative means the company is buying back shares.

Technical

BOM/524636 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.5

Neutral momentum band

Price vs 200-day MA

-10.3%

50/200-day relationship not available

Beta (5Y)

0.52

Less volatile than the market

Sharpe ratio

-0.63

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/524636

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/524636 stock rating?

bom/524636 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/524636 analysis?

The full report lives at /stocks/bom/524636/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/524636?

The latest report frames bom/524636 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/524636 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.